Biography
I primarily provide care for patients with malignant and non-malignant hematologic conditions.
Pharmacy School: Howard University College of Pharmacy (2019)
Residency Training:
- PGY1 Pharmacy Residency, New York-Presbyterian Hospital (2019-2020)
- PGY2 Oncology Pharmacy Residency, New York-Presbyterian Hospital (2020-2021)
Areas of interest:
- Malignant hematology
- Management of toxicities related to anticancer therapy
- Ooncology stewardship
Publications:
- Lee CS, Ahmed I, et al. A real world analysis of first line treatment of advanced EGFR mutated non-small cell lung cancer: A multi-center, retrospective study. J Oncol Pharm Pract. 2021;0(0)